247 related articles for article (PubMed ID: 2245615)
1. Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
McCormack DG; Barnes PJ; Evans TW
Crit Care Med; 1990 Dec; 18(12):1398-402. PubMed ID: 2245615
[TBL] [Abstract][Full Text] [Related]
2. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
Ono S; Westcott JY; Voelkel NF
J Appl Physiol (1985); 1992 Sep; 73(3):1084-92. PubMed ID: 1400021
[TBL] [Abstract][Full Text] [Related]
3. [Effects of the PAF antagonist WEB 2086 on hypoxia and angiotensin II-induced pulmonary vasoconstriction in the isolated perfused rat lung].
Kempfert C; Brandt R; Siewert B; Kanowski U; Oddoy A
Pneumologie; 1991 Oct; 45(10):799-803. PubMed ID: 1758848
[TBL] [Abstract][Full Text] [Related]
4. Effect of 5-lipoxygenase and cyclooxygenase blockade on porcine hemodynamics during continuous infusion of platelet-activating factor.
Olson NC; Kruse-Elliott KT; Johnson LW
Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):549-59. PubMed ID: 8415804
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
Chen CR; Voelkel NF; Chang SW
J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
[TBL] [Abstract][Full Text] [Related]
6. Sustained effects of platelet-activating factor infusion in piglets.
Stambouly JJ; Bradley LM; Czaja JF; Goldstein RE
Pediatr Res; 1991 Sep; 30(3):261-5. PubMed ID: 1945566
[TBL] [Abstract][Full Text] [Related]
7. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat.
McCormack DG; Barnes PJ; Evans TW
Clin Sci (Lond); 1989 Oct; 77(4):439-43. PubMed ID: 2805602
[TBL] [Abstract][Full Text] [Related]
8. A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine.
Siebeck M; Weipert J; Keser C; Kohl J; Spannagl M; Machleidt W; Schweiberer L
J Trauma; 1991 Jul; 31(7):942-9; discussion 949-50. PubMed ID: 1906548
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
10. Endothelin infusion reduces hypoxic pulmonary hypertension in pigs in vivo.
Liska J; Holm P; Owall A; Franco-Cereceda A
Acta Physiol Scand; 1995 Aug; 154(4):489-98. PubMed ID: 7484175
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
12. Delayed treatment with platelet activating factor receptor antagonist web 2086 attenuates pulmonary dysfunction in porcine endotoxin shock.
Siebeck M; Kohl J; Endres S; Spannagl M; Machleidt W
J Trauma; 1994 Nov; 37(5):745-51. PubMed ID: 7966471
[TBL] [Abstract][Full Text] [Related]
13. sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
Lundgren J; Kylhammar D; Hedelin P; Rådegran G
Acta Physiol (Oxf); 2012 Nov; 206(3):178-94. PubMed ID: 22682645
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of WEB 2086 and SRI 63-441 on TNF-alpha-induced alterations in cardiopulmonary function.
Kruse-Elliott KT; Dodam JR; Johnson LW; Olson NC
Am J Physiol; 1992 Sep; 263(3 Pt 2):H761-70. PubMed ID: 1415600
[TBL] [Abstract][Full Text] [Related]
15. Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs.
Yamada T; Yukioka H; Hayashi M; Asada A; Inoue M
Acta Anaesthesiol Scand; 1998 Mar; 42(3):358-68. PubMed ID: 9542566
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
Bando M; Ishii Y; Kitamura S; Ohno S
Respiration; 1998; 65(1):63-70. PubMed ID: 9523370
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport.
Horvath CJ; Kaplan JE; Malik AB
Am Rev Respir Dis; 1991 Dec; 144(6):1337-41. PubMed ID: 1741548
[TBL] [Abstract][Full Text] [Related]
19. PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction.
Chen CR; Voelkel NF; Chang SW
J Appl Physiol (1985); 1990 Mar; 68(3):1059-68. PubMed ID: 2341334
[TBL] [Abstract][Full Text] [Related]
20. Pertussis toxin attenuates platelet-activating factor-induced pulmonary hemodynamic alterations in pigs.
Olson NC; Kruse-Elliott KT; Whorton AR; Dodam JR
Am J Physiol; 1993 Mar; 264(3 Pt 1):L213-21. PubMed ID: 8460710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
